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The ABO blood type has been reported to be associated with several 
diseases such as hepatitis and malaria. Recently, some studies have 
reported that people with O blood type are protected against COVID-
19, while people with A blood type are more susceptible to contract 
this disease. Here, we analysed data from 5668 COVID-19 patients 
along with the same number of control samples in a study population 
in Iraq. Our analysis confirms that people with O blood type are 
protected partially against COVID-19. Notably, we demonstrate that 
people with RhD- are more susceptible to contract COVID-19 than 
people with RhD+ blood type. The blood types are associated with 
some clinical symptoms such as headache and asthenia of COVID-19, 
but there is no association with other symptoms. There is no 
association between blood types and deaths among COVID-19 
patients. This study suggests that in addition to ABO, RhD blood type 
influences the susceptibility to contract COVID-19. Overall, we 
conclude that susceptibility/protection against COVID-19 may not be 
determined based only on blood types among the global population 
as this might vary based on a number of other factors such as 
ethnicity, geographical locations, occupation and the level of exposure 
to infected people.
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Introduction
COVID-19 is caused by the newly identified severe acute 
respiratory syndrome coronavirus-2 (SARS-CoV-2), which ini-
tiated a pandemic in early 20201,2. Following initial infections 
in Wuhan, Hubei Province of China, it has affected almost all 
countries in the world, resulting in a significant number of deaths 
(over 1.1 million until October 2020) and increased economic 
burden worldwide. The primary symptoms of COVID-19 include 
a fever, persistent cough, dyspnoea, thrombosis, myalgia, fatigue, 
and, in some cases, decreased white blood cell count and severe 
pneumonia, which requires mechanical ventilation and other 
intensive care support. Although the relationship between ABO 
blood types and various diseases is poorly understood, blood 
types have been reported to be associated with several dis-
eases caused by organisms such as SARS-CoV-13, Helicobacter 
pylori4, hepatitis B virus5, Norwalk virus6, rotavirus and dengue 
virus, as well as malaria7. Similarly, the potential importance 
of ABO blood types in relevance to contracting COVID-19 
has been sparsely reported. While some studies found no 
significant correlation between blood types and the impact of 
COVID-198–10, others have reported that people with O blood 
type are partially protected against COVID-19 infection and 
people with A or AB blood type are more susceptible to this 
disease11–16. This could be due to the presence of anti-A17 and/or 
anti-B antibodies in the circulation and their ability to bind to 
the spike proteins of the virus, thereby preventing them enter-
ing cells and proliferating. Notably, a genome wide association 
study has confirmed the potential involvement of the ABO blood 
group system in contracting COVID-1918. Although few studies 
have specifically established an association between RhD blood 
type and susceptibility to COVID-19, a recent study reported 
a high risk association between RhD+, COVID-19 infection 
and resulting deaths13. However, the robust correlation between 
the blood types specifically RhD and COVID-19 infection has 
not yet been fully established. Hence, we explored the poten-
tial association between blood types, particularly RhD and 
COVID-19 in a study population of Iraq.
Methods
The aim of this study was to analyse the relationship between 
the blood types and COVID-19 associated complications 
in a small population of Iraq. Therefore, in this study, we 
collected data (i.e. blood group, primary symptoms, previ-
ous risk factors, age, gender and outcomes, severity level of 
COVID-19) from the records of 5,668 COVID-19 patients 
(confirmed as positive by real-time polymerase chain reac-
tion and this was considered as the key criteria for eligibility to 
be included in this study) who were admitted to Al-Hussein 
Teaching Hospital, Thi-Qar and Alkarama Teaching Hospital, 
Wasit in Iraq between March and June 2020. Blood type data, 
were collected from the same number of control (non-COVID-19) 
individuals from the same hospitals (using their records database) 
and matched by age and gender to the cases.
The sample size was based on the number of COVID-19 patients 
admitted in these two hospitals during the study period. The 
accuracy of data was thoroughly checked by healthcare 
professionals working in these hospitals and the authors prior to 
analysis. The individuals who were involved in data collection 
did not directly analyse the data. The data analysis (between 
COVID-19 and non COVID-19 groups) was performed by 
different authors using anonymised data in order to avoid any 
potential bias. All the statistical analyses were performed using 
Pearson’s Chi-square test and logistic regression models in 
R statistical package (www.r-project.org). 
This study design, data collection and consent were approved 
by the ethical committee (Ref no: 00563477) at Thi-Qar 
Health Directorate, the Ministry of Health, Republic of Iraq, 
and all the data were anonymised prior to analysis. Informed 
verbal consent was obtained from all patients to use their 
records, and where patients were minor (below 18 years old), 
consent was obtained from their parents or legal guardians. 
Verbal consent instead of written consent was obtained as the 
hospitals were very busy, as a result of the pandemic. Appropri-
ate permissions from the hospitals were also obtained to use the 
anonymised data for this study. 
Results
The COVID-19 population studied here consisted of 3691 
(65.2%) males and 1977 (34.8%) females. According to age group: 
≤10 years, 267 (4.7%); 11-20 years, 511 (9%); 21–30 years, 
1781 (31.4%); 31–40 years, 1221 (21.5%); 41–50 years, 870 
(15.3%); 51–60 years, 569 (10%); 61–70 years, 273 (4.8%); 
71–80 years, 138 (2.4%); 81–90 years, 32 (0.6%); 90+ years, 
6 (0.1%) (with the highest age being 100). The median age 
of the population was 33 years, and the most infected age 
group in this population was 21–30 years old.
Among COVID-19 patients, 1572 (27.7%) had blood type A 
(A+ = 1493; A- = 79), 1880 (33.2%) had B (B+ = 1653; B- = 
227), 645 (11.4%) had AB (AB+ = 511; AB- = 134) and 1571 
(27.7%) had O (O+ = 1495; O- = 76). The control population 
(5668, matched for age and sex) had a similar ratio of blood 
types [1454 (25.7%) people had A (A+ = 1405; A- = 49); 1792 
(31.6%) had B (B+ = 1692; B- = 100); 411 (7.3%) had AB 
(AB+ = 366; AB- = 45); 2011 (35.5%) had O (O+ = 1976; 
O- = 35)]. Among the control population, O+ was the most 
common blood type, and O- was the least common type with 
others being small population groups except A+ and B+.
There is very strong evidence (X2 = 209.51, df = 8, p <0.0001) 
for association between blood groups and COVID-19 infec-
tion among the study population. Exploring this association 
further demonstrates that the proportion of COVID-19 patients 
with O+ blood type is significantly lower than the con-
trol population, suggesting that this blood type is protective 
against this disease. In contrast, A-, AB-, AB+, B- and O- have 
shown increased susceptibility to COVID-19 compared to the 
control population (Figure 1A). Notably, COVID-19 patients 
with A+ and B+ blood types did not show any significant dif-
ference in the proportion infected when compared to the 
control group (Figure 1B). The risk of contracting COVID-19 
was higher among RhD- patients compared to the RhD+ patients 
[OR = 2.38, 95% CI (2.03, 2.79), p= 0.0001]. There is no evi-
dence for association between gender and blood type among 
COVID-19 patients (X2 = 4.97, df = 7, p = 0.664).
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The Sankey plot (Figure 1C) illustrates the association between 
different blood types and the severity of COVID-19 among 
patients (the severity level was classified according to the guide-
lines provided by the Ministry of Health in Iraq). In total, there 
were 77 patients classified as in ‘critical’ stage, and all of 
them died in hospital during treatment. A total of 90 patients 
were in the ‘severe’ category, of which only 4 recovered while 
the others died in hospitals. A further 4000 were in the ‘moder-
ate’ category and 1501 patients were listed as ‘mild’. Based on 
our analysis, there was no significant association between 
blood types and the severity of disease among these patients.
There is evidence for the association of some clinical symp-
toms with certain blood types among COVID-19 patients when 
adjusted for age, gender, severity of disease and risk factors. For 
example, asthenia is significantly lower in people with blood 
type B+ compared to individuals with O+ [OR = 0.98, 95% 
CI (0.96, 0.99), p= 0.004]. Similarly, experiencing a head-
ache was significantly lower in people with blood type AB+ 
compared to people with O+ [OR = 0.97, 95% CI (0.95, 0.99), 
p= 0.012]. It is noteworthy that the size of these effects is very 
small. There is no significant correlation between other clinical 
symptoms (such as fever, chills, cough, dyspnea, anosmia 
ageusia, loss of appetite, muscle ache, cyanosis, rhinorrhoea, 
sore throat, diarrhoea, nausea and vomiting) and blood types.
In total, 176 deaths were recorded in this study among COVID-19 
patients. However, there is no evidence for association of 
blood types, including RhD, with death due to COVID-19 
when adjustments were made for age, gender and risk factors 
(X2 = 0.037, df = 7, p = 0.999). The 172 patients who died were 
reported to have various preexisting health conditions as risk 
Figure 1. Frequency and proportion of various blood types in relation to COVID-19 and its severity. (A) the frequency of different 
blood types in the study population. (B) the proportions of controls and COVID-19 cases within different blood types. (C) the Sankey plot 
shows the relationship between blood types and severity of COVID-19 among the study population.
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factors. For example, 63 patients had hypertension, 19 had type 
2 diabetes and hypertension, 33 had only diabetes, 1 had type 
2 diabetes with acute renal failure, 1 had type 2 diabetes with 
atherosclerosis and another had diabetes with chronic kidney 
disease. Notably, 18 patients had chronic obstructive pulmo-
nary disease (COPD), 3 had COPD with diabetes, and one 
had COPD with hypertension. Another 3 patients had chronic 
kidney disease and 1 had chronic lung disease. In total, 17 patients 
had hypertension while 4 had acute renal failure and 4 had 
acute pulmonary conditions. Of the 5668 patients, only 37 were 
asymptomatic (hence fewer admission in hospitals) and others 
had one or more notable COVID-19 symptoms.
Discussion
The ABO blood types are known to be associated with 
several human diseases3–7. Similar to previous studies12,13, here 
we report that O+ blood type provides partial protection against 
COVID-19. While the association between RhD blood type and 
various diseases has not been fully established yet, RhD+ has 
been reported to be associated with high infection and death 
rate among COVID-19 patients in a population in the USA13. 
In contrast to this previous study13, interestingly, we report the 
significance of RhD blood type in influencing the susceptibility 
to contract COVID-19 among this study population; i.e. people 
with RhD- blood were more susceptible to contract COVID-19 
than people with RhD+ blood type. The mechanisms behind 
this protection/susceptibility are unclear and further research is 
warranted to unravel the underlying questions. Moreover, we 
emphasise that the association between blood types (ABO and 
RhD) and COVID-19 is likely to be based on numerous factors 
including (but not limited to) ethnicity, geographical location, 
nature of occupation and the exposure to infected patients. 
Data availability
Underlying data
University of Reading Research Data Archive: Blood types and 
their relationship with COVID-19 among a study population 
in Iraq, http://dx.doi.org/10.17864/1947.27819.
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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Sarah Jones  
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In this brief report, Majeed and colleagues investigate the relationship between blood groups and 
COVID19 susceptibility and severity. The study analyses data from 5668 COVID19 patients 
admitted to two hospitals in Iraq, and an equal number of matched controls admitted to the same 
hospitals during the study period. The study compares the frequency of blood groups in the study 
population and the proportions of controls and COVID19 patients within each blood type. The 
results demonstrate that within the O+ blood type, the proportion of COVID19 patients is 
significantly lower compared to controls, indicating reduced susceptibility to the virus. In contrast, 
in blood types A-, B-, AB-, O- and AB+ there is a higher proportion of COVID19 cases compared to 
controls, suggesting increased susceptibility. No relationship was found between blood group and 
disease severity. The methods are clearly reported, and the data appears sound. 
The report would benefit from a demographics table or information specifically relating to 
ethnicity. It has been established that ethnicity impacts susceptibility to SARs-CoV-2 and the 
distribution of blood groups vary between ethnic groups. Does the data represent a difference in 
ethnicity rather than blood group? And might this explain conflicting results with larger published 
studies concerning RhD status and COVID19 susceptibility? 
 
A few minor points to improve clarity:
It is clearly stated that O+ was the most common blood type in the control population, it 
would be useful to have a similar statement for the COVID19 group, stating the most 
common blood type. 
 
○
Also, to improve clarity it would be useful to present the data comparing the percentage of 
patients that are RhD- in each group.  It appears to be more than double in the COVID19 
group (Control 4%; COVID19 9.1%). 
 
○
The final statement, emphasising the factors likely to be responsible for the associations 
observed between the blood types and COVID19 requires further clarification and 
supporting citations. What is the evidence that the proportion of each blood type varies in 
different occupations or geographical locations? Were the study groups not all from the 
○
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same geographical location (local to the hospitals)? Presenting the ethnicity information for 
the study group would also help to address this point.
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